To examine whether this interaction occurred in HBL patients, we applied the chromatin immunoprecipitation (ChIP) approach and found that the β-catenin-TCF4-p300 complex is bound to CEGRs/ALCDs in five examined genes (Figure 2C). This evidence concerns the gene TCF4 and hepatoblastoma.